Wedbush Assumes Meta at Neutral, $671 Price Target

1 min read Reproduced verbatim
Rating
Neutral
Target
$671
Outcome
Reached
on July 15, 2026
Wedbush and Meta logos

What the analyst said

Wedbush analyst Ygal Arounian assumes coverage on Meta Platforms Inc.

(NASDAQ: META) with a Neutral rating and a price target of $671.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

META trades at $605. The 33 analysts who set a target in the last 3 months range from $650 to $1,000, with a median of $860. This $671 target is 22% below the median.

Since the note META has moved −8% (from $661). 12-month window: day 113 of 365, closes on July 15, 2027.

Track record

This call✓ Target reached on July 15, 2026, 0 days after the note.

Firm track recordWedbush: 65% of its 23 targets at least a year old were reached within 12 months (#20 of 26 firms); on Meta, 4 of 5. Accuracy ranking →

Wedbush on Meta

Wedbush price targets on Meta

3 calls from July 31, 2025 to July 30, 2026. The target went from $920 to $595 (−35%). The rating moved from Buy to Hold.

Wedbush targetMETA share price
  1. July 30, 2026Target cut from $671 (−11%)Hold$595
  2. July 15, 2026 This noteDowngraded to Hold, target cut from $920 (−27%)Hold$671
  3. July 31, 2025Earliest call shownBuy$920
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.